A quantitative method for collagen using lanthanide-assisted peptide probes

Through the lanthanide-assisted Linker-targeted polypeptide probe, the lanthanide ions are combined with specific peptides to form a probe with strong fluorescence signal, solving the problem of insufficient collagen detection signal in the prior art and realizing collagen The specific quantitative detection overcomes the limitations of insufficient fluorescence signal and insufficient specific binding capacity.

CN118755474BActive Publication Date: 2024-12-06TIANJIN BAOGANG RES INST OF RARE EARTHS CO LTD +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411239218.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-12-06
Estimated Expiration
2044-09-05

AI Technical Summary

Technical Problem

Existing peptide probes have problems such as insufficient fluorescence signal, limited spectral reusability and susceptibility to environmental factors when detecting collagen, which limits their ability to detect multiple biomarkers in complex disease systems.

Method used

Using lanthanide-assisted Linker-targeting polypeptide probes, a probe with a strong fluorescence signal is formed by binding lanthanide ions (such as Eu3+ and Gd3+) to a specific polypeptide, for quantitative detection of collagen. The probe includes targeted polypeptides such as HVWMQAP and (GOP)n sequences, Linker is Ahx, and the lanthanide assisted polypeptide probe structure is Eu-[Ahx-HVWMQAP]4 or Gd-[Ahx-HVWMQAP]4, by incubation and Clean and detect its fluorescence intensity.

Benefits of technology

The specific binding and quantitative detection of collagen is achieved, with strong fluorescence signal specificity, and can recognize denatured collagen in a variety of proteins, overcoming the problems of insufficient fluorescence signal and insufficient specific binding ability of the prior art. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118755474B_ABST
    Figure CN118755474B_ABST
Patent Text Reader

Abstract

The present invention provides a quantitative method for collagen using a lanthanide-assisted polypeptide probe, comprising the following steps: incubating and washing a collagen solution with a lanthanide-assisted polypeptide probe, and detecting the fluorescence intensity thereof; the lanthanide-assisted polypeptide probe is a Linker-targeted polypeptide chelated with a lanthanide ion. The lanthanide-assisted polypeptide probe of the present invention combines collagen polypeptide with lanthanide ions, and the formed polypeptide probe exhibits a strong fluorescence signal. The probe has strong specificity in a variety of proteins, and its performance of specifically binding to denatured collagen can be used for the quantification of collagen.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of detection, and in particular relates to a quantitative method for collagen using a lanthanide-assisted polypeptide probe. Background Art

[0002] Collagen is a key structural protein in the human body, forming a complex triple helical structure that gives mechanical strength to tissues. It plays a key role in maintaining the extracellular matrix, cell growth, differentiation, and various physiological functions. Abnormal synthesis and degradation of type I and type IV collagen are closely related to the multifaceted processes of tumor progression, invasion, and metastasis. Abnormal accumulation of type I and type IV collagen has been found in fibrotic lesions, while excessive degradation of type II collagen has been found during osteogenesis. Studies have found that an imbalance in collagen production and degradation may lead to serious diseases such as fibrosis, arthritis, and cancer, in which changes in the collagen environment may promote tumor growth and affect tissue mechanics. Therefore, the development of peptide probes that can detect collagen is of great significance for accurate clinical diagnosis.

[0003] Peptide probes combined with organic dyes such as fluorescein and anthocyanin have been widely studied for the detection of various collagens. HVWMQAP and KLWVLPK peptide probes modified with organic dyes showed selective targeting capabilities for type I and type IV collagen, respectively. In addition, the Cy5.5-labeled peptide probe WYRGRL has been used to visualize type II collagen in the knee joint. In addition, organic dyes are hampered by disadvantages such as photobleaching, limited spectral reusability, and susceptibility to environmental factors, which greatly restricts their ability to simultaneously detect multiple biomarkers in complex disease systems. Summary of the invention

[0004] In view of this, the present invention aims to overcome the defects in the prior art and proposes a quantitative method for collagen using a lanthanide-assisted polypeptide probe.

[0005] To achieve the above object, the technical solution of the present invention is achieved as follows:

[0006] A method for quantifying collagen using a lanthanide-assisted polypeptide probe comprises the following steps:

[0007] The collagen test solution is incubated and washed with the lanthanide-assisted polypeptide probe, and the fluorescence intensity is detected;

[0008] The lanthanide auxiliary polypeptide probe is a linker-targeting polypeptide chelated with lanthanide ions.

[0009] Further, the targeting polypeptide in the Linker-targeting polypeptide is polypeptide 1 or polypeptide 2, the amino acid sequence of polypeptide 1 is HVWMQAP, and the amino acid sequence of polypeptide 2 is (GOP)n, wherein n is an integer greater than 6. The amino acid sequence of polypeptide 1 is shown in SEQ ID NO. 1. GOP in polypeptide 2 is the abbreviation of Gly-Hyp-Pro, which means glycine-hydroxyproline-proline in Chinese.

[0010] Furthermore, the PI value of the polypeptide 1 is 6.79; and the PI value of the polypeptide 2 is 5.52.

[0011] Furthermore, the Linker in the Linker-targeting polypeptide is Ahx.

[0012] Furthermore, the structure of the Linker-targeting polypeptide of polypeptide 1 is Ahx-(GOP) 10 Or Ahx-HVWMQAP.

[0013] Further, the lanthanide ion is Eu 3+ ions and / or Gd 3+ ion.

[0014] Furthermore, the structure of the lanthanide auxiliary polypeptide probe is Eu-[Ahx-HVWMQAP]4 or Gd-[Ahx-HVWMQAP]4.

[0015] A lanthanide auxiliary polypeptide probe, wherein the lanthanide auxiliary polypeptide probe is a linker-targeting polypeptide chelated with a lanthanide ion; the lanthanide ion is Eu 3+ ions and / or Gd 3+ ion.

[0016] The method for preparing the lanthanide-assisted polypeptide probe comprises the following steps: firstly solid-phase synthesizing a linker and a polypeptide to form a linker-targeting polypeptide, and then chelating the lanthanide ions to the linker-targeting polypeptide.

[0017] Compared with the prior art, the present invention has the following advantages:

[0018] The present invention uses lanthanide elements to assist the polypeptide probe to combine collagen polypeptide with lanthanide ions, and the formed polypeptide probe exhibits a strong fluorescent signal. The probe has strong specificity in a variety of proteins, and its ability to specifically bind to denatured collagen can be used for the quantification of collagen. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The Eu-[Ahx-(GOP) described in Example 1 of the present invention10 ]3 Fluorescence intensity curves at different wavelengths;

[0020] Figure 2 The Eu-[Ahx-(GOP) described in Example 1 of the present invention 10 ]3 Fluorescence intensity curves at different mole fractions;

[0021] Figure 3 The ultraviolet absorption peaks of Ahx-HVWMQAP and Eu-[Ahx-HVWMQAP]4 described in Example 2 of the present invention;

[0022] Figure 4 The circular dichroism spectra of Ahx-HVWMQAP and Eu-[Ahx-HVWMQAP]4 described in Example 2 of the present invention;

[0023] Figure 5 The Eu-[Ahx-(GOP) described in Example 3 of the present invention 10 ]3 fluorescence intensity bar graph;

[0024] Figure 6 The Eu-[Ahx-(GOP) described in Example 3 of the present invention 10 ]3 Fluorescence intensity of type I collagen under different treatments;

[0025] Figure 7 The Eu-[Ahx-(GOP) described in Example 3 of the present invention 10 ]3 Fluorescence intensity of type I collagen with different concentrations. DETAILED DESCRIPTION

[0026] Unless otherwise defined, the technical terms used in the following examples have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods, unless otherwise specified, are all conventional methods.

[0027] The present invention will be described in detail below with reference to the embodiments.

[0028] Example 1 Preparation of a lanthanide-assisted peptide probe targeting denatured collagen

[0029] 1. Design of lanthanide-assisted peptide probe targeting denatured collagen

[0030] This embodiment adopts (GOP) 10 As a targeting peptide, (GOP) 10 The amino acid sequence is shown in SEQ ID NO.2; the structure of Linker-targeting polypeptide is Ahx-(GOP) 10; The structure of the lanthanide-assisted peptide probe is Eu-[Ahx-(GOP) 10 ]3.

[0031] 2. Preparation of peptides by solid phase synthesis

[0032] (1) Add 0.345 mmol / g Rink ammonia resin into a reactor with a sieve plate and use 5 mL of dichloromethane to swell the resin;

[0033] (2) The N-terminal Fmoc protecting group was removed by 20% piperidine / N,N-dimethylformamide (DMF) solution, and the complete removal of the protecting group was detected by colorimetric reaction;

[0034] (3) The amino acid (5 equiv) with Fmoc protection at the N-terminus, HOBt (5 equiv) and HBTU (5 equiv) were dissolved in DMF and activated at low temperature for 20 min. DIEA (8 equiv) was then added dropwise to the solution. The mixed solution was added to the reactor and reacted for 0.5-3 h.

[0035] (4) After the reaction, the reaction solution was withdrawn from the reactor, and the resin was washed three times with 10 mL of DMF and DCM respectively. The condensation of amino acids was detected by colorimetric reaction. The resin was treated with 20% piperidine / DMF solution for three times, for 5 min, 5 min and 15 min respectively. The resin was washed three times with 10 mL of DMF and DCM respectively. The removal of the protecting group was detected by colorimetric reaction.

[0036] (5) Repeat steps (3) and (4) until the target sequence peptide is synthesized; add 25% acetic anhydride to the reactor, and detect the completion of the reaction by colorimetric reaction. Wash the resin three times with 10 mL DMF and DCM respectively;

[0037] (6) The resin was washed three times with DCM and methanol respectively. The resin was drained and a cutting solution (TFA:TIS:water = 95:2.5:2.5) was added and reacted for 3 h.

[0038] (7) The reaction solution was added to icy ether to precipitate the peptide. The precipitate was collected by centrifugation, dissolved with a small amount of TFA, and precipitated again by adding excess icy ether and centrifuged. The precipitate was washed twice with icy ether and air-dried to obtain a crude peptide. The crude peptide was purified by reverse phase liquid chromatography to obtain a pure peptide.

[0039] 3. Preparation of lanthanide-assisted peptide probes targeting denatured collagen

[0040] The Ahx-targeting peptide synthesized above was dissolved in DMSO to prepare a 0.5 mM solution, and 5 mM EuCl3•6H2O was added and stirred for 1-3 h, and dialyzed in a dialysis bag to obtain the lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3.

[0041] 4. Characterization of lanthanide-assisted peptide probes targeting denatured collagen

[0042] The above lanthanide-assisted peptide probe: Eu-[Ahx-(GOP) 10 The fluorescence spectra and binding ratio of ]3 were recorded by RF6000 fluorescence spectrophotometer (Shimadzu SSL, Kyoto, Japan).

[0043] The results are as follows Figure 1-2 As shown, Eu-[Ahx-(GOP) 10 ]3 Fluorescence spectrum results show 7 different spectral bands in the wavelength range of 470-700 nm, which include transitions from the 5D4 excited state to various 7FJ (J=6-0) energy levels, among which the transition from 5D4 to 5F5 at 545 nm is the most prominent. b is the binding ratio of Eu to Ahx-HVWMQAP. The intensity of the fluorescence emission peak changes with the increase of the molar fraction of the polypeptide and lanthanide ions through titration experiments. When the molar fraction is 0.72, the intensity of the fluorescence emission peak is the largest.

[0044] Example 2 Ultraviolet absorption and circular dichroism characterization of lanthanide-assisted peptide probes

[0045] The obtained lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3 and Eu-[Ahx-HVWMQAP]4 were characterized by UV-visible absorption spectra and circular dichroism spectra, respectively. The UV-visible absorption spectra were recorded by a UV-1750 spectrophotometer (Shimadzu Corporation, Kyoto, Japan); the circular dichroism spectra were recorded by an Aviv model 400 circular dichroism spectrometer (Applied Photophysics Ltd, UK) UV-1750. The temperature of the cuvette was controlled by a Peltier temperature controller.

[0046] Figure 3 Ahx-HVWMQAP peptide probe plus Eu 3+ UV absorption peaks before and after; Figure 4 Add Eu to Ahx-HVWMQAP peptide probe 3+The circular dichroism spectra before and after these results show that there is no obvious change in the spectral peaks before and after the addition of lanthanide ions to the Ahx-targeting peptide.

[0047] Example 3 Characterization of the targeting properties of lanthanide-assisted peptide probes targeting denatured collagen

[0048] PBS solution was prepared with gelatin solution, type I collagen, bovine serum albumin, human serum albumin, hemoglobin, trypsin and pepsin. 100 μL of protein solution was added to 96-well plates and incubated at 4 °C for 5 h to allow complete protein binding. The protein solution was poured off and 100 μL of lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3 was added to the wells and incubated at 4 °C for 4 h. The wells were washed with PBS solution for 3-5 min each time. The fluorescence intensity (ex: 280 nm, em: 545 nm) was measured on an Infinite M200 multifunctional microplate reader (TECAN, Switzerland). Each measurement was repeated three times.

[0049] The results are as follows Figure 5 As shown: from left to right: gelatin, type I collagen, bovine serum albumin, human serum albumin, hemoglobin, trypsin and pepsin. The results show that: the signal of type I collagen is relatively weak, indicating that the lanthanide-assisted polypeptide probe has poor binding ability with type I collagen; the signals of bovine serum albumin, human serum albumin, hemoglobin, trypsin and pepsin are very weak, indicating that the lanthanide-assisted polypeptide probe has weak binding ability with bovine serum albumin, human serum albumin, hemoglobin, trypsin and pepsin; the gelatin signal is significantly stronger than type I collagen, bovine serum albumin, human serum albumin, hemoglobin, trypsin and pepsin, indicating that the lanthanide-assisted polypeptide probe can specifically recognize denatured collagen.

[0050] Example 4 Characterization of lanthanide-assisted peptide probes targeting denatured type I collagen

[0051] PBS solution was prepared with type I collagen, heat-denatured collagen, and SDS-treated type I collagen. 100 μL of protein solution was added to a 96-well plate and incubated at 4 °C for 3-5 h to allow complete protein binding. The protein solution was poured off and 100 μL of lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3 was added to the wells and incubated at 4 °C for 2-4 h. The wells were washed with PBS solution for 3-5 min each time. The fluorescence intensity (ex: 280 nm, em: 545 nm) was measured on an Infinite M200 multifunctional microplate reader (TECAN, Switzerland). Each measurement was repeated three times.

[0052] When studying the treatment of type I collagen with different concentrations of SDS, the lanthanide-assisted peptide probe was mixed with type I collagen treated with different concentrations of SDS (0-10%) and incubated at 4 °C for 2-5 h. The protein solution was poured off and washed with PBS solution three times, each time for 3-5 min. The fluorescence intensity (ex: 280 nm, em: 545 nm) was measured on an Infinite M200 multifunctional microplate reader (TECAN, Switzerland). Each measurement was repeated three times.

[0053] The results are as follows Figure 6-7 As shown, Figure 6 From left to right, they are type I collagen, heat-denatured type I collagen, and SDS-treated type I collagen. The results show that the signal of type I collagen is very weak, indicating that the lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3 has a weak ability to bind to type I collagen; the signals of heat-denatured type I collagen and SDS-treated type I collagen are significantly stronger than those of type I collagen, indicating that the lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3 can specifically recognize denatured type I collagen. Figure 7 At the maximum fluorescence emission wavelength of 545 nm, as the concentration of type I collagen treated with SDS continued to increase, the lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 The fluorescence intensity of ]3 was continuously enhanced. When the lanthanide-assisted peptide probe was treated with type I collagen at 1% or higher SDS concentration, the lanthanide-assisted peptide probe Eu-[Ahx-(GOP) 10 ]3's fluorescence intensity no longer increases.

[0054] Comparative Example 1 The PI of the targeting peptide is different

[0055] Compared with Example 1, the difference is that the types of targeting polypeptides are different, and polypeptides with different PI values ​​such as polypeptide PI=12.48, 10.03, 8.75, and 6.17 are used to replace to prepare probes. It is found that the four probes obtained by using targeting polypeptides with other PI values ​​have no specific response to multiple proteins and cannot be used as probes for identifying collagen.

[0056] Comparative Example 2 The sequences of the targeting peptides are different

[0057] Compared with Example 1, the difference is that the types of targeting polypeptides are different. In this comparative example, polypeptides with different sequences such as SSKPAKRVRVRARK, AATSSSKQKRSRKK, YKGSNRGTKRKRKN, SSTSTTAKRKL (produced by Shanghai Chupeptide Biotechnology Co., Ltd.) are used to replace and prepare probes. It is found that the four probes formed after the introduction of polypeptides of different sequences have basically no fluorescence emission signals and cannot be used as probes for identifying collagen.

[0058] Comparative Example 3 Selection of Different Linkers

[0059] Compared with Example 1, the difference is that 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and n-hydroxysulfosuccinimide (NHS) were selected as linkers for experiments, and it was found that the fluorescence performance of the polypeptide probe was low, indicating that the linker selected in the present invention has a strong affinity and forms a more stable polypeptide probe.

[0060] Comparative Example 4 Lanthanide ions are different

[0061] Compared with Example 1, the difference is that the lanthanide ions are different. This comparative example uses La 3+ and Ce 3+ The probes were prepared, and the fluorescence signals of the two probes obtained showed obvious quenching response, making it impossible to carry out the subsequent collagen recognition experiment.

[0062] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A lanthanide-assisted polypeptide probe, characterized in that: The lanthanide auxiliary polypeptide probe is a linker-targeting polypeptide chelated with a lanthanide ion; the lanthanide ion is Eu 3+ ions; the structure of the Linker-targeting polypeptide is Ahx-(GOP) 10 ; GOP is the abbreviation of Gly-Hyp-Pro, which means glycine-hydroxyproline-proline in Chinese.

2. The method for preparing the lanthanide-assisted polypeptide probe according to claim 1, characterized in that: The method comprises the following steps: firstly solid-phase synthesizing a Linker and a polypeptide to form a Linker-targeting polypeptide, and then chelating lanthanide ions to the Linker-targeting polypeptide.